# Bridge Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bridge-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: US
- Website: www.bridgecro.com
- Total disclosed funding: $61M
- Latest round: Series C (Feb 13, 2007)
- Investors on record: 5

## About

Bridge Pharmaceuticals is the leading preclinical contract research organization in US. It include general and specialized toxicology, developmental and reproductive toxicology (DART), safety pharmacology, carcinogenicity testing and vaccine development in support of IND and NDA submissions.

## Funding rounds

- Series C, Feb 13, 2007, $35M — Granite Asia, Aisling Capital, WI Harper Group, Lehman Brothers, SRI International
- Series B, May 31, 2006, $22M — WI Harper Group
- Series A, Apr 1, 2004, $3.5M — WI Harper Group

## Investors

- WI Harper Group (https://capitalatlas.ai/funds/wi-harper-group) — Series A, Series B, Series C
- Granite Asia (https://capitalatlas.ai/funds/granite-asia) — Series C
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series C
- Lehman Brothers (https://capitalatlas.ai/funds/lehman-brothers) — Series C
- SRI International — Series C